BBIO
BridgeBio Pharma Inc
NASDAQ: BBIO · HEALTHCARE · BIOTECHNOLOGY
$70.94
+1.76% today
Updated 2026-04-29
Market cap
$13.75B
P/E ratio
—
P/S ratio
27.39x
EPS (TTM)
$-3.78
Dividend yield
—
52W range
$32 – $85
Volume
2.5M
BridgeBio Pharma Inc (BBIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $40.56M | $8.25M | $69.72M | $77.65M | $9.30M | $221.90M | $502.08M |
| Revenue growth (YoY) | — | — | — | -79.7% | +745.1% | +11.4% | -88.0% | +2285.3% | +126.3% |
| Cost of revenue | $260000.00 | — | $2.50M | $3.09M | $3.11M | $3.43M | $2.45M | $3.88M | $28.27M |
| Gross profit | $-260000.00 | — | $38.06M | $8.25M | $66.60M | $74.21M | $6.86M | $218.02M | $473.81M |
| Gross margin | — | — | 93.8% | 100.0% | 95.5% | 95.6% | 73.7% | 98.3% | 94.4% |
| R&D | $30.56M | $140.07M | $209.95M | $337.05M | $451.02M | $399.46M | $455.71M | $506.46M | $477.54M |
| SG&A | $13.30M | $43.59M | $94.35M | $145.68M | $192.21M | $143.19M | $150.59M | $250.93M | $531.23M |
| Operating income | $-43.86M | $-183.66M | $-266.24M | $-474.48M | $-576.63M | $-512.20M | $-607.37M | $-592.97M | $-569.09M |
| Operating margin | — | — | -656.4% | -5752.0% | -827.1% | -659.6% | -6528.8% | -267.2% | -113.3% |
| EBITDA | $-43.56M | $-183.41M | $-278.96M | $-467.38M | $-533.83M | $-397.44M | $-565.47M | $-436.83M | $-672.88M |
| EBITDA margin | — | — | -687.8% | -5665.9% | -765.7% | -511.9% | -6078.3% | -196.9% | -134.0% |
| EBIT | $-43.82M | $-183.66M | $-279.82M | $-468.83M | $-539.68M | $-404.21M | $-571.96M | $-442.90M | $-681.88M |
| Interest expense | $13000.00 | $2.55M | $8.77M | $36.66M | $46.78M | $80.44M | $81.29M | $99.29M | $53.10M |
| Income tax | $-13.49M | $16.76M | $-28.15M | $-21.56M | $52.84M | $9.31M | $71.51M | $1.15M | — |
| Effective tax rate | 30.6% | -14.7% | 9.8% | 4.6% | -10.4% | -2.0% | -12.5% | -0.2% | 0.0% |
| Net income | $-30.57M | $-130.75M | $-260.44M | $-448.72M | $-562.54M | $-481.18M | $-643.20M | $-535.76M | $-729.31M |
| Net income growth (YoY) | — | -327.8% | -99.2% | -72.3% | -25.4% | +14.5% | -33.7% | +16.7% | -36.1% |
| Profit margin | — | — | -642.1% | -5439.7% | -806.9% | -619.7% | -6913.9% | -241.4% | -145.3% |